SELLAS Life Sciences Group Inc.

SLS | NASDAQ

$11.86

+$0.49 (+4.31%)

Sep 22, 2026, 11:22 AM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	71.89M	13.89M	2.53M	17.13M	21.46M	35.3M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	-184K	n/a	n/a
Other Long-Term Assets	257K	466K	275K	399K	594K	614K
Receivables	n/a	n/a	n/a	n/a	n/a	1.13M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	223K	100K	100K	330K	27K	130K
Total Current Assets	75.21M	16.33M	3.17M	17.76M	23.04M	36.93M
Property-Plant & Equipment	963K	925K	858K	874K	723K	896K
Goodwill & Intangibles	1.91M	1.91M	1.91M	1.91M	1.91M	7.61M
Total Long-Term Assets	3.13M	3.31M	3.05M	3.19M	3.38M	9.12M
Total Assets	78.35M	19.43M	6.22M	20.94M	26.43M	46.05M
Account Payables	2.95M	3.5M	5.64M	3.36M	2.14M	4.66M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	5.6M
Short-Term Debt	544K	n/a	n/a	n/a	198K	n/a
Other Current Liabilities	1.77M	1.82M	1.54M	5.5M	1.65M	1.01M
Total Current Liabilities	7.02M	9.51M	13.74M	15.52M	4.98M	12.34M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	4K	336K	4.69M
Total Long-Term Liabilities	457K	457K	460K	577K	1.1M	5.75M
Total Liabilities	7.47M	9.97M	14.2M	16.09M	6.08M	18.09M
Total Debt	1M	1M	906K	945K	808K	991K
Book Value	70.87M	9.47M	-7.98M	4.85M	20.35M	27.96M
Book Value Per Share	0.65	0.15	-0.29	0.25	1.31	3.51
Common Stock	15K	7K	3K	2K	2K	1K
Retained Earnings	-274.99M	-248.13M	-217.24M	-179.9M	-138.6M	-117.9M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	70.87M	9.47M	-7.98M	4.85M	20.35M	27.96M
Total Investments	n/a	n/a	n/a	-184K	n/a	n/a